Activation of the renin-angiotensin system in hyperoxia-induced lung fibrosis in neonatal rats

Neonatology

Volumn 101, Issue 1, 2011, Pages 47-54

  Jiang, Jiunn Song ^a,c   Lang, Yaw Dong ^b   Chou, Hsiu Chu ^d   Shih, Chwen Ming ^d   Wu, Meng Ying ^d   Chen, Chung Ming ^d,e   Wang, Leng Fang ^d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bronchopulmonary dysplasia; Collagen; Hyperoxia; Renin angiotensin system

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOCHEMISTRY; HYPEROXIA; LUNG FIBROSIS; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPEROXIA; LUNG; MAP KINASE SIGNALING SYSTEM; OXYGEN; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

RATTUS;

EID: 79960661157     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000329451     Document Type: Article

References (21)

1. Coalson JJ: Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81. (Pubitemid 36356495)
2. Speer CP: Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361.
3. Bland RD: Neonatal chronic lung disease in the post-surfactant era. Biol Neonate 2005; 88: 181-191.
4. Ratner V, Slinko S, Utkina-Sosunova I, Starkov A, Polin RA, Ten VS: Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia. Neonatology 2009; 95: 299-305.
5. Suki B, Ito S, Stamenovic D, Lutchen KR, Ingenito EP: Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J Appl Physiol 2005; 98: 1892-1899. (Pubitemid 40570805)
6. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ: Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol 2004; 286:L156-L164. (Pubitemid 38055871)
7. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S: Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax 2004; 59: 31-38. (Pubitemid 38067969)
8. Lang YD, Hung CL, Wu TY, Wang LF, Chen CM: The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts. Free Radic Biol Med 2010; 49: 88-95.
9. Chen CM, Wang LF, Chou HC, Lan YD, Yi-Ping Lai: Up-regulation of connective tissue growth factor in hyperoxia-induced lung fibrosis. Pediatr Res 2007; 62: 128-133. (Pubitemid 47205708)
10. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210. (Pubitemid 351160157)
11. Cairns JA, Walls AF: Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 313-1321.
12. Zhang K, Rekhter MD, Gordon D, Phan S:Co-expression of α -smooth muscle actin and type I collagen in fibroblast-like cells of rat lungs with bleomycin-induced pulmonary fibrosis: a combined immuno-histochemical and in situ hybridization study. Am J Pathol 1994; 145: 114-125.
13. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363. (Pubitemid 34619269)
14. Baker KM, Chernin MI, Wixson SK, Aceto JF: Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990; 259:H324-H332. (Pubitemid 20259406)
15. Waseda Y, Yasui M, Nishizawa Y, Inuzuka K, Takato H, Ichikawa Y, Tagami A, Fujimura M, Nakao S: Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice. Respir Res 2008; 9: 43-51.
16. Li Z, Carter JD, Dailey LA, Huang YC: Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type 1 receptor. Environ Health Perspect 2005; 113: 1009-1014. (Pubitemid 41149630)
17. Tryka AF, Witschi H, Gosslee DG, McArthur AH, Clapp NK: Patterns of cell proliferation during recovery from oxygen injury: species differences. Am Rev Respir Dis 1986; 133: 1055-1059. (Pubitemid 16090011)
18. Kirk JM, Heard BE, Kerr I, Turner-Warwick M, Laurent GJ: Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll Relat Res 1984; 4: 169-821.
19. Liebler JM, Qu Z, Buckner B, Powers MR, Rosenbaum JT: Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998; 53: 823-829. (Pubitemid 28459537)
20. Rehan V, Torday J: Hyperoxia augments pulmonary lipofibroblast-to- myofibroblast transdifferentiation. Cell Biochem Biophys 2003; 38: 239-250.
21. Genest J, Cantin M, Garcia R, Thibault G, Gutkowska J, Schiffrin E, Kuchel O, Hamet P. Extrarenal angiotensin-forming enzymes. Clin Exp Hypertens A 1983; 5: 1065-1080. (Pubitemid 13013694)